7th Annual Updates in Cardiopulmonary Disease Conference

7th Annual Updates in Cardiopulmonary Disease Conference is organized by Kalispell Regional Healthcare (KRH) and will be held from Oct 05 - 06, 2018 at The Lodge At Whitefish Lake, Whitefish, Montana, United States of America.

The target audience for this medical event is encompasses a wide spectrum of healthcare providers including cardiopulmonary specialists, family practitioners, internists, hospitalists, emergency medicine practitioners, physician assistants, nurse practitioners, nurses, cardiac rehabilitation specialists, and other interested allied health care providers. This CME Conference has been approved for a maximum of 8.5 AMA PRA Category 1 Credits.

Course Description:
Providers should be able to formulate a practical approach to common cardiopulmonary disorders, identify the appropriate diagnostic tests, make an accurate diagnosis, discuss the various treatment options, and recognize when to treat and when to refer cardiopulmonary patients. This activity is expected to result in increased confidence in making an appropriate diagnosis and treatment decision with the ultimate goal of improving patient outcomes

Course Objectives:
• List top ten advances in critical care medicine that improves patient outcomes since 2000.
• Identify the basic mechanism of action, therapeutic effects and common adverse effects of each class of lipid-lowering agents.
• Discuss lipid goals and major risk factors for atherosderosis.
• Review clinical data supporting PCSK9 therapy.
• Identify patient populations ideal for PCSK9 therapy and way to get insurance approval.
• Describe treatment and management strategies for peripheral vascular disease.
• Discuss initial management strategies for ischemic heart disease.
• Describe the challenges in diagnosing and defining diastolic heart failure with preserved ejection fraction.
• Compare the differences between systolic heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF), and recovered EF.
• Describe new and evolving therapeutic options in heart failure with reduced ejection fraction (HFrEF).
• Compare the therapeutic approaches to heart failure with preserved ejection fraction (HFpEF).
• Describe the history of cardiac catheterization.
• Differentiate between diagnostic and therapeutic cardiac catheterization.
• List cardiology strategies for primary prevention of heart disease.
• Explain pharmaceutical interventions approved for secondary prevention.
• Describe the controversy's regarding proper target for blood pressure reduction in patients with hypertension.
• Review updates in electrophysiology as it relates to ventricular tachycardia.
• Define Palliative Care/Support Cases Services related to the cardiopulmonary patient.
• Review treatment strategies for end stage cardiopulmonary disease.
• Review the key recommendations for assessment and intervention of pneumonia.

Additional details will be posted as soon as they are available.